A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors

NCT07050459 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumors

Interventions

DRUG: SIM0686
DRUG: SIM0686

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.